Overview on Chronic Viral Cardiomyopathy/Chronic Myocarditis

作者: H. -P. Schultheiss , U. Kühl

DOI: 10.1007/3-540-30822-9_1

关键词: FulminantBiopsyDilated cardiomyopathyTroponinSudden deathPathologyMedicineEnterovirusMyocarditisViral cardiomyopathy

摘要: Myocarditis is most often induced by cardiotropic viruses and resolves with minimal cardiac remodelling without discernable prognostic impact. Acute myocarditis has a highly diverse clinical presentation (asymptomatic, infarct-like presentation, atrioventricular (AV)-block, atrial fibrillation, sudden death due to ventricular tachycardia, fulminant severely depressed contractility). Progression of its sequela, dilated cardiomyopathy (DCM), been documented in 20% cases pathogenically linked chronic inflammation viral persistence. Persistence (enterovirus, adenovirus) constitutes one the predominant aetiological factors DCM. Additionally, circulating autoantibodies distinct autoantigens have described patients DCM, providing evidence for autoimmune involvement. Since complaints DCM are unspecific, positive effect any specific therapy depends on an accurate biopsy-based diagnosis characterization histological, immunohistological molecular biological methods (PCR), which developed into sensitive tools detection different viruses, active replication, myocardial inflammation. The immunohistochemical infiltrates supported new era compared Dallas criteria, led entity secondary cardiomyopathies acknowledged WHO, inflammatory (DCMi). Immunohistochemically quantified lymphocytes significantly better reflect troponin levels correlate findings anti-myosin scintigraphy histological analysis. Furthermore, orchestrated induction endothelial cell adhesion molecules (CAMs) 65% confirmed that CAM prerequisite lymphocytic infiltration DCMi. combination these diagnostic techniques virus analysis allows further classification differentiating disease subgroups virus-positive virus-negative or Further Th1-/Th2-immune response may provide additional information natural course disease. This differential improves management indispensable development antiviral immunomodulatory treatment strategies.

参考文章(49)
Wolfgang Ch. Poller, H. Fechner, M. Noutsias, C. Tschoepe, H.-P. Schultheiss, Highly variable expression of virus receptors in the human cardiovascular system Zeitschrift für Kardiologie. ,vol. 91, pp. 978- 991 ,(2002) , 10.1007/S00392-002-0862-7
Andrea Frustaci, Cristina Chimenti, Fiorella Calabrese, Maurizio Pieroni, Gaetano Thiene, Attilio Maseri, Immunosuppressive Therapy for Active Lymphocytic Myocarditis: Virological and Immunologic Profile of Responders Versus Nonresponders Circulation. ,vol. 107, pp. 857- 863 ,(2003) , 10.1161/01.CIR.0000048147.15962.31
Matthias Pauschinger, Kumaran Chandrasekharan, Michel Noutsias, Uwe K�hl, Lothar Peter Schwimmbeck, Heinz-Peter Schultheiss, Viral heart disease: molecular diagnosis, clinical prognosis, and treatment strategies Medical Microbiology and Immunology. ,vol. 193, pp. 65- 69 ,(2004) , 10.1007/S00430-003-0213-Y
ARTHUR J. HAUCK, DEBRA L. KEARNEY, WILLIAM D. EDWARDS, Evaluation of Postmortem Endomyocardial Biopsy Specimens From 38 Patients With Lymphocytic Myocarditis: Implications for Role of Sampling Error Mayo Clinic Proceedings. ,vol. 64, pp. 1235- 1245 ,(1989) , 10.1016/S0025-6196(12)61286-5
Heribert Schunkert, Ulrich Broeckel, Hans W Hense, Ulrich Keil, Guenter AJ Riegger, Left-ventricular dysfunction The Lancet. ,vol. 351, pp. 372- ,(1998) , 10.1016/S0140-6736(05)78298-2
R. Kandolf, D. Ameis, P. Kirschner, A. Canu, P. H. Hofschneider, In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease Proceedings of the National Academy of Sciences of the United States of America. ,vol. 84, pp. 6272- 6276 ,(1987) , 10.1073/PNAS.84.17.6272
C. Baboonian, T. Treasure, Meta-analysis of the association of enteroviruses with human heart disease Heart. ,vol. 78, pp. 539- 543 ,(1997) , 10.1136/HRT.78.6.539
J. Towbin, N. Bowles, Molecular genetics of left ventricular dysfunction. Current Molecular Medicine. ,vol. 1, pp. 81- 90 ,(2001) , 10.2174/1566524013364077